The Key Factors If You Desire To Master The NLG919-Scene Is Fairly Easy!

Матеріал з HistoryPedia
Версія від 14:19, 1 квітня 2017, створена Bronzeedge83 (обговореннявнесок) (Створена сторінка: More patients in the first period had mucositis and soft-tissue infection as the origin of BSI, but an endogenous source was more common during the second. Gram...)

(різн.) ← Попередня версія • Поточна версія (різн.) • Новіша версія → (різн.)
Перейти до: навігація, пошук

More patients in the first period had mucositis and soft-tissue infection as the origin of BSI, but an endogenous source was more common during the second. Gram-positive BSI was more frequent in the first period (64% versus 41%; p Romidepsin research buy versus 6%; p LMTK2 agents of BSI in patients with cancer who are neutropenic [2]. During the next two decades, the causes of BSI shifted dramatically from GNB to gram-positive cocci, especially viridans group streptococci (VGS) and coagulase-negative staphylococci [3�C5]. Importantly, about 11% of episodes of VGS bacteraemia find more presented with serious clinical complications such as septic shock and adult respiratory distress syndrome, leading to significant mortality [6]. Streptococcus mitis was most frequently the species causing these infections [6]. In addition, some of these strains were resistant to penicillin and presented diminished susceptibility to other ��-lactams, particularly ceftazidime [3,6�C8]. Some of the factors associated with the shift towards more gram-positive infecting organisms included oral mucositis as a result of the increasing use of certain chemotherapeutic drugs, such as cytosine arabinoside, profound and prolonged neutropenia, increasing use of central venous catheters, trimethoprim�Csulfamethoxazole and fluoroquinolone prophylaxis and use of antacids and histamine 2 blockers [9,10]. Changes in the general management of patients with haematological malignancies are still ongoing, with the introduction of newer types of myeloablative chemotherapy and transplants, newer immunosuppressive agents, and changes in the antibacterial and antifungal prophylaxis. These changes may have influenced the characteristics of BSI during neutropenia, which remains a major cause of mortality in this patient population.